# Kymos

> Kymos Group


## Pages

- [Viral Vectors Characterization](https://pre.kymos.com/services/cmc-analysis-quality-control/viral-vectors-characterization-v2/)
- [固态分析](https://pre.kymos.com/zh-hans/%e6%9c%8d%e5%8a%a1%e9%a1%b9%e7%9b%ae/%e5%9b%ba%e6%80%81%e5%88%86%e6%9e%90/)
- [Solid-State Analysis](https://pre.kymos.com/services/solid-state-analysis/)
- [Anàlisi d'estat sòlid](https://pre.kymos.com/ca/serveis/analisi-destat-solid/)
- [Análisis de estado sólido](https://pre.kymos.com/es/servicios/analisis-estado-solido/)
- [Analyse de l’état solide](https://pre.kymos.com/fr/services/analyse-de-letat-solide/)
- [Festkörperanalytik](https://pre.kymos.com/de/dienstleistungen/festkorperanalytik/)
- [Analisi dello stato solido](https://pre.kymos.com/it/servizi/analisi-dello-stato-solido/)
- [고체 상태 분석](https://pre.kymos.com/ko/%ec%84%9c%eb%b9%84%ec%8a%a4/%ea%b3%a0%ec%b2%b4-%ec%83%81%ed%83%9c-%eb%b6%84%ec%84%9d/)
- [Kymos 丹麦：位于哥本哈根的分析型 CRO](https://pre.kymos.com/zh-hans/kymos-%e4%b8%b9%e9%ba%a6%ef%bc%9a%e4%bd%8d%e4%ba%8e%e5%93%a5%e6%9c%ac%e5%93%88%e6%a0%b9%e7%9a%84%e5%88%86%e6%9e%90%e5%9e%8b-cro/)
- [Kymos Denmark: Analytical CRO in Copenhagen](https://pre.kymos.com/particle/)
- [Kymos Dinamarca: CRO analítica a Copenhaguen](https://pre.kymos.com/ca/particula/)
- [Kymos Dinamarca: CRO analítica en Copenhague](https://pre.kymos.com/es/particula/)
- [Kymos Danemark : CRO analytique à Copenhague](https://pre.kymos.com/fr/particule/)
- [Kymos Dänemark: Analytisches CRO in Kopenhagen](https://pre.kymos.com/de/teilchen/)
- [Kymos Danimarca: CRO analitica a Copenaghen](https://pre.kymos.com/it/particella/)
- [Kymos 덴마크: 코펜하겐 소재 분석 CRO](https://pre.kymos.com/ko/%ec%9e%85%ec%9e%90/)
- [Animal Health](https://pre.kymos.com/services/pre-clinical-clinical-services/animal-health/)
- [Estudis Veterinaris](https://pre.kymos.com/ca/serveis/serveis-preclinics-i-clinics/estudis-veterinaris/)
- [Estudios Veterinarios](https://pre.kymos.com/es/servicios/servicios-preclinicos-y-clinicos/estudios-veterinarios/)
- [动物健康](https://pre.kymos.com/zh-hans/%e6%9c%8d%e5%8a%a1%e9%a1%b9%e7%9b%ae/%e4%b8%b4%e5%ba%8a%e5%89%8d%e5%92%8c%e4%b8%b4%e5%ba%8a%e6%9c%8d%e5%8a%a1/%e5%8a%a8%e7%89%a9%e5%81%a5%e5%ba%b7/)
- [동물 건강](https://pre.kymos.com/ko/%ec%84%9c%eb%b9%84%ec%8a%a4/%ec%a0%84%ec%9e%84%ec%83%81-%eb%b0%8f-%ec%9e%84%ec%83%81-%ec%84%9c%eb%b9%84%ec%8a%a4/%eb%8f%99%eb%ac%bc-%ea%b1%b4%ea%b0%95/)
- [Santé animale](https://pre.kymos.com/fr/services/services-precliniques-et-cliniques/sante-animale/)
- [Salute degli animali](https://pre.kymos.com/it/servizi/servizi-preclinici-e-clinici/salute-degli-animali/)
- [Tiergesundheit](https://pre.kymos.com/de/dienstleistungen/praeklinische-und-klinische-dienstleistungen/tiergesundheit/)
- [寡核苷酸质量控制](https://pre.kymos.com/zh-hans/%e6%9c%8d%e5%8a%a1%e9%a1%b9%e7%9b%ae/cmc-%e5%88%86%e6%9e%90%e4%b8%8e%e8%b4%a8%e9%87%8f%e6%8e%a7%e5%88%b6/%e5%af%a1%e6%a0%b8%e8%8b%b7%e9%85%b8%e8%b4%a8%e9%87%8f%e6%8e%a7%e5%88%b6/)
- [Quality Control of Oligonucleotides](https://pre.kymos.com/services/cmc-analysis-quality-control/quality-control-oligos/)
- [Control de qualitat d'oligonucleòtids](https://pre.kymos.com/ca/serveis/cmc-analisi-i-control-de-qualitat/control-qualitat-oligos/)
- [Control de calidad de oligonucleótidos](https://pre.kymos.com/es/servicios/analisis-y-control-de-calidad-de-cmc/control-calidad-oligos/)
- [Contrôle qualité des oligonucléotides](https://pre.kymos.com/fr/services/analyse-cmc-et-controle-qualite/controle-de-la-qualite-des-oligonucleotides/)
- [Qualitätskontrolle von Oligonukleotiden](https://pre.kymos.com/de/dienstleistungen/cmc-analyse-und-qualitaetskontrolle/qualitaetskontrolle-von-oligonukleotiden/)
- [올리고뉴클레오티드의 품질 관리](https://pre.kymos.com/ko/%ec%84%9c%eb%b9%84%ec%8a%a4/cmc-%eb%b6%84%ec%84%9d-%eb%b0%8f-%ed%92%88%ec%a7%88-%ea%b4%80%eb%a6%ac/%ec%98%ac%eb%a6%ac%ea%b3%a0%eb%89%b4%ed%81%b4%eb%a0%88%ec%98%a4%ed%8b%b0%eb%93%9c%ec%9d%98-%ed%92%88%ec%a7%88-%ea%b4%80%eb%a6%ac/)
- [Controllo di qualità degli oligonucleotidi](https://pre.kymos.com/it/servizi/analisi-cmc-e-controllo-qualita/controllo-di-qualita-degli-oligonucleotidi/)
- [Gezeiten (Oligo & Peptide)](https://pre.kymos.com/de/dienstleistungen/gezeiten-oligo-peptide/)
- [Marées (Oligo et Peptides)](https://pre.kymos.com/fr/services/marees-oligo-et-peptides/)
- [TIDES（寡核苷酸与多肽）](https://pre.kymos.com/zh-hans/%e6%9c%8d%e5%8a%a1%e9%a1%b9%e7%9b%ae/tides%ef%bc%88%e5%af%a1%e6%a0%b8%e8%8b%b7%e9%85%b8%e4%b8%8e%e5%a4%9a%e8%82%bd%ef%bc%89/)
- [TIDES (Oligo y Péptidos)](https://pre.kymos.com/es/servicios/mareas-oligo-y-peptidos/)
- [Tides (Oligo & Peptides)](https://pre.kymos.com/services/tides-oligo-peptides/)
- [TIDES (oligo i pèptids)](https://pre.kymos.com/ca/serveis/marees-oligo-i-peptids/)
- [타이드(올리고 & 펩타이드)](https://pre.kymos.com/ko/%ec%84%9c%eb%b9%84%ec%8a%a4/%ed%83%80%ec%9d%b4%eb%93%9c%ec%98%ac%eb%a6%ac%ea%b3%a0-%ed%8e%a9%ed%83%80%ec%9d%b4%eb%93%9c/)
- [Maree (oligo e peptidi)](https://pre.kymos.com/it/servizi/maree-oligo-e-peptidi/)
- [Anàlisi de Matèries Primeres](https://pre.kymos.com/ca/serveis/cmc-analisi-i-control-de-qualitat/assajos-de-materies-primeres/)
- [Raw Material Testing](https://pre.kymos.com/services/cmc-analysis-quality-control/raw-material-testing/)
- [原材料测试](https://pre.kymos.com/zh-hans/%e6%9c%8d%e5%8a%a1%e9%a1%b9%e7%9b%ae/cmc-%e5%88%86%e6%9e%90%e4%b8%8e%e8%b4%a8%e9%87%8f%e6%8e%a7%e5%88%b6/%e5%8e%9f%e6%9d%90%e6%96%99%e6%a3%80%e6%b5%8b/)
- [원자재 테스트](https://pre.kymos.com/ko/%ec%84%9c%eb%b9%84%ec%8a%a4/cmc-%eb%b6%84%ec%84%9d-%eb%b0%8f-%ed%92%88%ec%a7%88-%ea%b4%80%eb%a6%ac/%ec%9b%90%ec%9e%90%ec%9e%ac-%ed%85%8c%ec%8a%a4%ed%8a%b8/)
- [Rohmaterialprüfung](https://pre.kymos.com/de/dienstleistungen/cmc-analyse-und-qualitaetskontrolle/rohmaterialpruefung/)
- [Tests des matières premières](https://pre.kymos.com/fr/services/analyse-cmc-et-controle-qualite/tests-des-matieres-premieres/)
- [Test delle materie prime](https://pre.kymos.com/it/servizi/analisi-cmc-e-controllo-qualita/test-delle-materie-prime/)
- [Prueba de materia prima](https://pre.kymos.com/es/servicios/analisis-y-control-de-calidad-de-cmc/prueba-de-materia-prima/)
- [바이오의약품 및 바이오시밀러](https://pre.kymos.com/ko/%ec%84%9c%eb%b9%84%ec%8a%a4/%ec%83%9d%eb%ac%bc%ed%95%99%ec%a0%9c%ec%99%80-%eb%b0%94%ec%9d%b4%ec%98%a4%ec%8b%9c%eb%b0%80%eb%9f%ac/)
- [Farmaci biologici e biosimilari](https://pre.kymos.com/it/servizi/farmaci-biologici-e-biosimilari/)
- [Biologika und Biosimilars](https://pre.kymos.com/de/dienstleistungen/biologika-und-biosimilars/)
- [Produits biologiques et biosimilaires](https://pre.kymos.com/fr/services/produits-biologiques-et-biosimilaires/)
- [生物制品和生物类似药](https://pre.kymos.com/zh-hans/%e6%9c%8d%e5%8a%a1%e9%a1%b9%e7%9b%ae/%e7%94%9f%e7%89%a9%e5%88%b6%e5%93%81%e5%92%8c%e7%94%9f%e7%89%a9%e7%b1%bb%e4%bc%bc%e8%8d%af/)
- [Kleine Moleküle](https://pre.kymos.com/de/dienstleistungen/kleine-molekuele/)
- [小分子](https://pre.kymos.com/zh-hans/%e6%9c%8d%e5%8a%a1%e9%a1%b9%e7%9b%ae/%e5%b0%8f%e5%88%86%e5%ad%90/)
- [Piccole molecole](https://pre.kymos.com/it/servizi/piccole-molecole/)
- [细胞与基因治疗](https://pre.kymos.com/zh-hans/%e6%9c%8d%e5%8a%a1%e9%a1%b9%e7%9b%ae/%e7%bb%86%e8%83%9e%e4%b8%8e%e5%9f%ba%e5%9b%a0%e6%b2%bb%e7%96%97/)
- [Small Molecules](https://pre.kymos.com/services/small-molecules/)
- [Terapias celulares y génicas](https://pre.kymos.com/es/servicios/terapias-celulares-genicas/)
- [Petites molècules](https://pre.kymos.com/ca/serveis/molecules-petites/)
- [Petites molécules](https://pre.kymos.com/fr/services/petites-molecules/)
- [Moléculas pequeñas](https://pre.kymos.com/es/servicios/moleculas-pequenas/)
- [세포 & 유전자 치료제](https://pre.kymos.com/ko/%ec%84%9c%eb%b9%84%ec%8a%a4/%ec%84%b8%ed%8f%ac-%eb%b0%8f-%ec%9c%a0%ec%a0%84%ec%9e%90-%ec%b9%98%eb%a3%8c/)
- [Terapie cellulari e geniche](https://pre.kymos.com/it/servizi/terapie-cellulari-geniche/)
- [Biologics and Biosimilars](https://pre.kymos.com/services/biologics-and-biosimilars/)
- [Productes biològics i biosimilars](https://pre.kymos.com/ca/serveis/biologics-i-biosimilars/)
- [Thérapies cellulaires & géniques](https://pre.kymos.com/fr/services/therapies-cellulaires-geniques/)
- [Cell & Gene Therapies](https://pre.kymos.com/services/cell-gene-therapies/)
- [Teràpies cel·lulars i gèniques](https://pre.kymos.com/ca/serveis/terapies-cellulars-geniques/)
- [Biológicos y biosimilares](https://pre.kymos.com/es/servicios/productos-biologicos-y-biosimilares/)
- [저분자](https://pre.kymos.com/ko/%ec%84%9c%eb%b9%84%ec%8a%a4/%ec%86%8c%eb%b6%84%ec%9e%90/)
- [Zell- & Gentherapien](https://pre.kymos.com/de/dienstleistungen/zell-gentherapien/)
- [病毒载体表征](https://pre.kymos.com/zh-hans/%e6%9c%8d%e5%8a%a1%e9%a1%b9%e7%9b%ae/cmc-%e5%88%86%e6%9e%90%e4%b8%8e%e8%b4%a8%e9%87%8f%e6%8e%a7%e5%88%b6/%e7%97%85%e6%af%92%e8%bd%bd%e4%bd%93%e8%a1%a8%e5%be%81/)
- [Viral Vectors Characterization](https://pre.kymos.com/services/cmc-analysis-quality-control/viral-vector-characterization/)
- [Caracterització de vectors virals](https://pre.kymos.com/ca/serveis/cmc-analisi-i-control-de-qualitat/terapies-avancades/)
- [Caracterización de vectores virales](https://pre.kymos.com/es/servicios/analisis-y-control-de-calidad-de-cmc/caracterizacion-de-vectores-virales/)
- [Caratterizzazione dei vettori virali](https://pre.kymos.com/it/servizi/analisi-cmc-e-controllo-qualita/caratterizzazione-dei-vettori-virali/)
- [Charakterisierung viraler Vektoren](https://pre.kymos.com/de/dienstleistungen/cmc-analyse-und-qualitaetskontrolle/charakterisierung-viraler-vektoren/)
- [Caractérisation des vecteurs viraux](https://pre.kymos.com/fr/services/analyse-cmc-et-controle-qualite/caracterisation-des-vecteurs-viraux/)
- [바이러스 벡터 특성화](https://pre.kymos.com/ko/%ec%84%9c%eb%b9%84%ec%8a%a4/cmc-%eb%b6%84%ec%84%9d-%eb%b0%8f-%ed%92%88%ec%a7%88-%ea%b4%80%eb%a6%ac/%eb%b0%94%ec%9d%b4%eb%9f%ac%ec%8a%a4-%eb%b2%a1%ed%84%b0-%ed%8a%b9%ec%84%b1%ed%99%94/)
- [Anàlisi transdèrmic](https://pre.kymos.com/ca/serveis/cmc-analisi-i-control-de-qualitat/analisi-transdermic/)
- [透皮测试](https://pre.kymos.com/zh-hans/%e6%9c%8d%e5%8a%a1%e9%a1%b9%e7%9b%ae/cmc-%e5%88%86%e6%9e%90%e4%b8%8e%e8%b4%a8%e9%87%8f%e6%8e%a7%e5%88%b6/%e9%80%8f%e7%9a%ae%e6%b5%8b%e8%af%95/)
- [Pruebas Transdérmicas](https://pre.kymos.com/es/servicios/analisis-y-control-de-calidad-de-cmc/pruebas-transdermicas/)
- [Transdermale Prüfung](https://pre.kymos.com/de/dienstleistungen/cmc-analyse-und-qualitaetskontrolle/transdermales-testen/)
- [Tests transdermiques](https://pre.kymos.com/fr/services/analyse-cmc-et-controle-qualite/tests-transdermiques/)
- [Transdermal Testing](https://pre.kymos.com/services/cmc-analysis-quality-control/transdermal-testing/)
- [경피 시험](https://pre.kymos.com/ko/%ec%84%9c%eb%b9%84%ec%8a%a4/cmc-%eb%b6%84%ec%84%9d-%eb%b0%8f-%ed%92%88%ec%a7%88-%ea%b4%80%eb%a6%ac/%ea%b2%bd%ed%94%bc-%ed%85%8c%ec%8a%a4%ed%8a%b8/)
- [Test transdermici](https://pre.kymos.com/it/servizi/analisi-cmc-e-controllo-qualita/test-transdermici/)
- [Blog](https://pre.kymos.com/news/)
- [Blog](https://pre.kymos.com/ca/news/)
- [Blog](https://pre.kymos.com/it/blog/)
- [Blog](https://pre.kymos.com/es/news/)
- [博客](https://pre.kymos.com/zh-hans/%e5%8d%9a%e5%ae%a2/)
- [블로그](https://pre.kymos.com/ko/%eb%b8%94%eb%a1%9c%ea%b7%b8/)
- [Blog](https://pre.kymos.com/de/blog/)
- [Blog](https://pre.kymos.com/fr/blog/)
- [바이오마커 분석](https://pre.kymos.com/ko/%ec%84%9c%eb%b9%84%ec%8a%a4/%ec%a0%84%ec%9e%84%ec%83%81-%eb%b0%8f-%ec%9e%84%ec%83%81-%ec%84%9c%eb%b9%84%ec%8a%a4/%eb%b0%94%ec%9d%b4%ec%98%a4%eb%a7%88%ec%bb%a4-%eb%b6%84%ec%84%9d/)
- [Analisi dei biomarcatori](https://pre.kymos.com/it/servizi/servizi-preclinici-e-clinici/analisi-dei-biomarcatori/)
- [Biomarker-Analyse](https://pre.kymos.com/de/dienstleistungen/praeklinische-und-klinische-dienstleistungen/biomarkeranalyse/)
- [Dosage des biomarqueurs](https://pre.kymos.com/fr/services/services-precliniques-et-cliniques/analyse-des-biomarqueurs/)


## Documentation



## Posts

- [Anticuerpos biespecíficos: retos en los estudios farmacocinéticos e inmunogenicidad](https://pre.kymos.com/es/news/anticuerpos-biespecificos-retos-en-los-estudios-farmacocineticos-e-inmunogenicidad/)
- [Anticorps bispécifiques : défis dans les études de pharmacocinétique et d’immunogénicité](https://pre.kymos.com/fr/news/anticorps-bispecifiques-defis-dans-les-etudes-de-pharmacocinetique-et-dimmunogenicite/)
- [Anticossos biespecífics: reptes en estudis farmacocinètics i d'immunogenicitat](https://pre.kymos.com/ca/news/anticossos-biespecifics-reptes-en-estudis-farmacocinetics-i-dimmunogenicitat/)
- [Bispezifische Antikörper: Herausforderungen in pharmakokinetischen und Immunogenitätsstudien](https://pre.kymos.com/de/news/bispezifische-antikoerper-herausforderungen-in-pharmakokinetischen-und-immunogenitaetsstudien/)
- [이중특이성 항체: 약동학 및 면역원성 연구의 과제](https://pre.kymos.com/ko/news/%ec%9d%b4%ec%a4%91%ed%8a%b9%ec%9d%b4%ec%84%b1-%ed%95%ad%ec%b2%b4-%ec%95%bd%eb%8f%99%ed%95%99-%eb%b0%8f-%eb%a9%b4%ec%97%ad%ec%9b%90%ec%84%b1-%ec%97%b0%ea%b5%ac%ec%9d%98-%ea%b3%bc%ec%a0%9c/)
- [Anticorpi Bispecifici: Sfide negli Studi di Farmacocinetica e Immunogenicità](https://pre.kymos.com/it/news/anticorpi-bispecifici-sfide-negli-studi-di-farmacocinetica-e-immunogenicita/)
- [双特异性抗体：药代动力学和免疫原性研究中的挑战](https://pre.kymos.com/zh-hans/news/%e5%8f%8c%e7%89%b9%e5%bc%82%e6%80%a7%e6%8a%97%e4%bd%93%ef%bc%9a%e8%8d%af%e4%bb%a3%e5%8a%a8%e5%8a%9b%e5%ad%a6%e5%92%8c%e5%85%8d%e7%96%ab%e5%8e%9f%e6%80%a7%e7%a0%94%e7%a9%b6%e4%b8%ad%e7%9a%84%e6%8c%91/)
- [Bispecific Antibodies: Challenges in Pharmacokinetic and Immunogenicity Studies](https://pre.kymos.com/news/bispecific-antibodies-bioanalysis/)
- [Particle Characterization Method Transfer: Mastersizer 2000 to 3000 & Zetasizer Nano to Ultra](https://pre.kymos.com/news/mastersizer-2000-3000-zetasizer-method-transfer/)
- [Transferència de mètodes de caracterització de partícules: de Mastersizer 2000 a 3000 i de Zetasizer Nano a Ultra](https://pre.kymos.com/ca/news/ich-q1-un-marc-consolidat-per-a-les-proves-destabilitat-de-productes-biologics-2/)
- [Transfert de méthode de caractérisation des particules : Mastersizer 2000 vers 3000 & Zetasizer Nano vers Ultra](https://pre.kymos.com/fr/news/ich-q1-un-cadre-consolide-pour-les-essais-de-stabilite-des-produits-biologiques-2/)
- [Methodentransfer für Partikelcharakterisierung: Mastersizer 2000 zu 3000 & Zetasizer Nano zu Ultra](https://pre.kymos.com/de/news/ich-q1-ein-konsolidierter-rahmen-fur-stabilitatsprufungen-von-biologika/)
- [Trasferimento di metodi di caratterizzazione delle particelle: da Mastersizer 2000 a 3000 e da Zetasizer Nano a Ultra](https://pre.kymos.com/it/news/ich-q1-un-quadro-consolidato-per-i-test-di-stabilita-dei-biologici-2/)
- [입자 특성 분석 방법 이관: Mastersizer 2000에서 3000으로 & Zetasizer Nano에서 Ultra로](https://pre.kymos.com/ko/news/ich-q1-%ec%83%9d%eb%ac%bc%ed%95%99%ec%a0%81-%ec%a0%9c%ec%a0%9c-%ec%95%88%ec%a0%95%ec%84%b1-%ec%8b%9c%ed%97%98%ec%9d%84-%ec%9c%84%ed%95%9c-%ed%86%b5%ed%95%a9-%ed%94%84%eb%a0%88%ec%9e%84%ec%9b%8c-2/)
- [Transferencia de Métodos de Caracterización de Partículas: Mastersizer 2000 a 3000 y Zetasizer Nano a Ultra](https://pre.kymos.com/es/news/ich-q1-un-marco-consolidado-para-los-ensayos-de-estabilidad-de-productos-biologicos-2/)
- [颗粒表征方法转移：Mastersizer 2000 至 3000 以及 Zetasizer Nano 至 Ultra](https://pre.kymos.com/zh-hans/news/%e9%a2%97%e7%b2%92%e8%a1%a8%e5%be%81%e6%96%b9%e6%b3%95%e8%bd%ac%e7%a7%bb%ef%bc%9amastersizer-2000-%e8%87%b3-3000-%e4%bb%a5%e5%8f%8a-zetasizer-nano-%e8%87%b3-ultra/)
- [Biodistributions- und Shedding-Studien für ATMPs und Gentherapien: Ein praktisches FAQ](https://pre.kymos.com/de/news/biodistributions-und-shedding-studien-fuer-atmps-und-gentherapien-ein-praktisches-faq/)
- [Estudis de biodistribució i eliminació (shedding) per a ATMP i teràpies gèniques: preguntes freqüents pràctiques](https://pre.kymos.com/ca/news/estudis-de-biodistribucio-i-eliminacio-shedding-per-a-atmp-i-terapies-geniques-preguntes-frequents-practiques/)
- [Estudios de biodistribución y diseminación para ATMP y terapias génicas: preguntas frecuentes prácticas](https://pre.kymos.com/es/news/estudios-de-biodistribucion-y-diseminacion-para-atmp-y-terapias-genicas-preguntas-frecuentes-practicas/)
- [ATMP 및 유전자 치료제를 위한 생체 분포 및 배출 연구: 실용적인 FAQ](https://pre.kymos.com/ko/news/atmp-%eb%b0%8f-%ec%9c%a0%ec%a0%84%ec%9e%90-%ec%b9%98%eb%a3%8c%ec%a0%9c%eb%a5%bc-%ec%9c%84%ed%95%9c-%ec%83%9d%ec%b2%b4-%eb%b6%84%ed%8f%ac-%eb%b0%8f-%eb%b0%b0%ec%b6%9c-%ec%97%b0%ea%b5%ac-%ec%8b%a4/)
- [Studi di biodistribuzione e shedding per ATMP e terapie geniche: FAQ pratiche](https://pre.kymos.com/it/news/studi-di-biodistribuzione-e-shedding-per-atmp-e-terapie-geniche-faq-pratiche/)
- [Études de biodistribution et d’excrétion pour les MTI et les thérapies géniques : FAQ pratique](https://pre.kymos.com/fr/news/etudes-de-biodistribution-et-dexcretion-pour-les-mti-et-les-therapies-geniques-faq-pratique/)
- [Biodistribution and Shedding Studies for ATMPs and Gene Therapies: A Practical FAQ](https://pre.kymos.com/news/biodistribution-shedding-studies-atmp-gene-therapy/)
- [ATMP 和基因疗法的生物分布与排出研究：实用常见问题解答](https://pre.kymos.com/zh-hans/news/atmp-%e5%92%8c%e5%9f%ba%e5%9b%a0%e7%96%97%e6%b3%95%e7%9a%84%e7%94%9f%e7%89%a9%e5%88%86%e5%b8%83%e4%b8%8e%e6%8e%92%e5%87%ba%e7%a0%94%e7%a9%b6%ef%bc%9a%e5%ae%9e%e7%94%a8%e5%b8%b8%e8%a7%81%e9%97%ae/)
- [ICH Q1: A Consolidated Framework for Stability Testing of Biologics](https://pre.kymos.com/news/ich-q1-stability-biologics/)
- [ICH Q1：生物制品稳定性试验的整合框架](https://pre.kymos.com/zh-hans/news/ich-q1%ef%bc%9a%e7%94%9f%e7%89%a9%e5%88%b6%e5%93%81%e7%a8%b3%e5%ae%9a%e6%80%a7%e8%af%95%e9%aa%8c%e7%9a%84%e6%95%b4%e5%90%88%e6%a1%86%e6%9e%b6/)
- [ICH Q1: Un Marco Consolidado para los Ensayos de Estabilidad de Productos Biológicos](https://pre.kymos.com/es/news/ich-q1-un-marco-consolidado-para-los-ensayos-de-estabilidad-de-productos-biologicos/)
- [ICH Q1: 생물학적 제제 안정성 시험을 위한 통합 프레임워크](https://pre.kymos.com/ko/news/ich-q1-%ec%83%9d%eb%ac%bc%ed%95%99%ec%a0%81-%ec%a0%9c%ec%a0%9c-%ec%95%88%ec%a0%95%ec%84%b1-%ec%8b%9c%ed%97%98%ec%9d%84-%ec%9c%84%ed%95%9c-%ed%86%b5%ed%95%a9-%ed%94%84%eb%a0%88%ec%9e%84%ec%9b%8c/)
- [ICH Q1: un quadro consolidato per i test di stabilità dei biologici](https://pre.kymos.com/it/news/ich-q1-un-quadro-consolidato-per-i-test-di-stabilita-dei-biologici/)
- [ICH Q1: Ein konsolidierter Rahmen für Stabilitätsprüfungen von Biologika](https://pre.kymos.com/de/news/ich-q1-ein-konsolidierter-rahmen-fuer-stabilitaetspruefungen-von-biologika/)
- [ICH Q1 : un cadre consolidé pour les essais de stabilité des produits biologiques](https://pre.kymos.com/fr/news/ich-q1-un-cadre-consolide-pour-les-essais-de-stabilite-des-produits-biologiques/)
- [ICH Q1: un marc consolidat per a les proves d'estabilitat de productes biològics](https://pre.kymos.com/ca/news/ich-q1-un-marc-consolidat-per-a-les-proves-destabilitat-de-productes-biologics/)
- [Cannabinoid Bioanalysis: A Validated Multi-Analyte LC-MS/MS Method in Human Plasma](https://pre.kymos.com/news/cannabinoid-bioanalysis/)
- [Bioanàlisi de cannabinoides: un mètode LC-MS/MS multianàlit validat en plasma humà](https://pre.kymos.com/ca/news/solucions-integrals-per-a-estudis-preclinics-de-salut-animal-de-bioequivalencia-i-clinics/)
- [Bioanalyse des cannabinoïdes : une méthode LC-MS/MS multi-analyte validée dans le plasma humain](https://pre.kymos.com/fr/news/solutions-tout-en-un-pour-les-etudes-precliniques-de-sante-animale-de-bioequivalence-et-cliniques/)
- [Cannabinoid-Bioanalyse: Eine validierte Multi-Analyt-LC-MS/MS-Methode in menschlichem Plasma](https://pre.kymos.com/de/news/one-stop-shop-losungen-fur-praklinische-studien-tiergesundheit-bioaquivalenz-und-klinische-studien/)
- [칸나비노이드 생체 분석: 인체 혈장에서 검증된 다중 분석물 LC-MS/MS 방법](https://pre.kymos.com/ko/news/%ec%a0%84%ec%9e%84%ec%83%81-%eb%8f%99%eb%ac%bc-%ea%b1%b4%ea%b0%95-%ec%83%9d%eb%ac%bc%ed%95%99%ec%a0%81%eb%8f%99%eb%93%b1%ec%84%b1-%eb%b0%8f-%ec%9e%84%ec%83%81-%ec%8b%9c%ed%97%98%ec%9d%84-%ec%9c%84/)
- [Bioanalisi dei cannabinoidi: un metodo LC-MS/MS multi-analita validato in plasma umano](https://pre.kymos.com/it/news/soluzioni-one-stop-shop-per-studi-preclinici-di-salute-animale-di-bioequivalenza-e-clinici/)
- [Bioanálisis de cannabinoides: un método validado multianalito de LC-MS/MS en plasma humano](https://pre.kymos.com/es/news/soluciones-integrales-para-estudios-preclinicos-de-sanidad-animal-bioequivalencia-y-clinicos/)
- [大麻素生物分析：人血浆中经过验证的多分析物 LC-MS/MS 方法](https://pre.kymos.com/zh-hans/news/%e5%a4%a7%e9%ba%bb%e7%b4%a0%e7%94%9f%e7%89%a9%e5%88%86%e6%9e%90%ef%bc%9a%e4%ba%ba%e8%a1%80%e6%b5%86%e4%b8%ad%e7%bb%8f%e8%bf%87%e9%aa%8c%e8%af%81%e7%9a%84%e5%a4%9a%e5%88%86%e6%9e%90%e7%89%a9-lc-ms-ms/)
- [One-Stop-Shop solutions for Preclinical, Animal Health, Bioequivalence, and Clinical Studies](https://pre.kymos.com/news/one-stop-solution/)
- [Solucions integrals per a estudis preclínics, de salut animal, de bioequivalència i clínics](https://pre.kymos.com/ca/news/usp-materials-extraibles-i-lixiviables-en-sistemes-dun-sol-us/)
- [Solutions tout-en-un pour les études précliniques, de santé animale, de bioéquivalence et cliniques](https://pre.kymos.com/fr/news/usp-substances-extractibles-et-lixiviables-dans-les-systemes-a-usage-unique-2/)
- [One-Stop-Shop-Lösungen für präklinische Studien, Tiergesundheit, Bioäquivalenz und klinische Studien](https://pre.kymos.com/de/news/usp-extrahierbare-und-auslaugbare-stoffe-in-einwegsystemen-2/)
- [전임상, 동물 건강, 생물학적동등성 및 임상 시험을 위한 원스톱 솔루션](https://pre.kymos.com/ko/news/%eb%af%b8%ea%b5%ad-%ed%8a%b9%ed%97%88-%ec%9d%bc%ed%9a%8c%ec%9a%a9-%ec%8b%9c%ec%8a%a4%ed%85%9c%ec%9d%98-%ec%b6%94%ec%b6%9c%eb%ac%bc-%eb%b0%8f-%ec%9a%a9%ec%b6%9c%eb%ac%bc-2/)
- [Soluzioni One-Stop-Shop per studi preclinici, di salute animale, di bioequivalenza e clinici](https://pre.kymos.com/it/news/usp-sostanze-estraibili-e-rilasciabili-nei-sistemi-monouso-2/)
- [Soluciones integrales para estudios preclínicos, de sanidad animal, bioequivalencia y clínicos](https://pre.kymos.com/es/news/usp-extraibles-y-lixiviables-en-sistemas-de-un-solo-uso-2/)
- [适用于临床前、动物保健、生物等效性和临床研究的一站式解决方案](https://pre.kymos.com/zh-hans/news/%e9%80%82%e7%94%a8%e4%ba%8e%e4%b8%b4%e5%ba%8a%e5%89%8d%e3%80%81%e5%8a%a8%e7%89%a9%e4%bf%9d%e5%81%a5%e3%80%81%e7%94%9f%e7%89%a9%e7%ad%89%e6%95%88%e6%80%a7%e5%92%8c%e4%b8%b4%e5%ba%8a%e7%a0%94%e7%a9%b6/)
- [Kymos Group expands with the acquisition of Particle Analytical](https://pre.kymos.com/news/kymos-group-acquires-particle-analytical/)
- [Kymos Group se expande con la adquisición de Particle Analytical](https://pre.kymos.com/es/news/kymos-group-acquires-particle-analytical/)
- [Kymos Group si espande con l'acquisizione di Particle Analytical](https://pre.kymos.com/it/news/kymos-group-si-espande-con-lacquisizione-di-particle-analytical/)
- [Kymos Group s'expandeix amb l'adquisició de Particle Analytical](https://pre.kymos.com/ca/news/kymos-group-sexpandeix-amb-ladquisicio-de-particle-analytical/)
- [Kymos Group, Particle Analytical 인수로 사업 확장](https://pre.kymos.com/ko/news/kymos-group-particle-analytical-%ec%9d%b8%ec%88%98%eb%a1%9c-%ec%82%ac%ec%97%85-%ed%99%95%ec%9e%a5/)
- [Kymos Group expandiert durch die Übernahme von Particle Analytical](https://pre.kymos.com/de/news/kymos-group-expandiert-durch-die-uebernahme-von-particle-analytical/)
- [Kymos Group s'agrandit avec l'acquisition de Particle Analytical](https://pre.kymos.com/fr/news/kymos-group-sagrandit-avec-lacquisition-de-particle-analytical/)
- [Kymos 集团通过收购 Particle Analytical 进一步扩张](https://pre.kymos.com/zh-hans/news/kymos-%e9%9b%86%e5%9b%a2%e9%80%9a%e8%bf%87%e6%94%b6%e8%b4%ad-particle-analytical-%e8%bf%9b%e4%b8%80%e6%ad%a5%e6%89%a9%e5%bc%a0/)
- [Kymos Group celebrates 25 years #SupportingScience](https://pre.kymos.com/news/25-years-anniversary/)
- [Kymos Group festeggia 25 anni #SostenereLaScienza](https://pre.kymos.com/it/news/kymos-group-festeggia-25-anni-sostenerelascienza/)
- [Kymos Group célèbre ses 25 ans #SupportingScience](https://pre.kymos.com/fr/news/kymos-group-celebre-ses-25-ans-supportingscience/)
- [Die Kymos Group feiert 25 Jahre #SupportingScience](https://pre.kymos.com/de/news/die-kymos-group-feiert-25-jahre-supportingscience/)
- [Kymos Group celebra 25 anys #SupportingScience](https://pre.kymos.com/ca/news/kymos-group-celebra-25-anys-supportingscience/)
- [Kymos Group celebra 25 años #SupportingScience](https://pre.kymos.com/es/news/kymos-group-celebra-25-anos-supportingscience/)
- [Kymos Group 25주년 기념 #SupportingScience](https://pre.kymos.com/ko/news/kymos-group-25%ec%a3%bc%eb%85%84-%ea%b8%b0%eb%85%90-supportingscience/)
- [Kymos 集团庆祝成立 25 周年 #SupportingScience](https://pre.kymos.com/zh-hans/news/kymos-%e9%9b%86%e5%9b%a2%e5%ba%86%e7%a5%9d%e6%88%90%e7%ab%8b-25-%e5%91%a8%e5%b9%b4-supportingscience/)
- [USP <665>/<1665>: Extractables & Leachables in Single-Use-Systems](https://pre.kymos.com/news/usp665-extractables-leachables-in-single-use-systems/)
- [USP<665> /<1665> Materials extraïbles i lixiviables en sistemes d'un sol ús](https://pre.kymos.com/ca/news/usp-materials-extraibles-i-lixiviables-en-sistemes-d39un-sol-us/)
- [USP<665> /<1665> Substances extractibles et lixiviables dans les systèmes à usage unique](https://pre.kymos.com/fr/news/usp-substances-extractibles-et-lixiviables-dans-les-systemes-a-usage-unique/)
- [USP<665> /<1665> Extrahierbare und auslaugbare Stoffe in Einwegsystemen](https://pre.kymos.com/de/news/usp-extrahierbare-und-auslaugbare-stoffe-in-einwegsystemen/)
- [USP<665> /<1665> : Sostanze estraibili e rilasciabili nei sistemi monouso](https://pre.kymos.com/it/news/usp-sostanze-estraibili-e-rilasciabili-nei-sistemi-monouso/)
- [USP<665> /<1665> Extraíbles y lixiviables en sistemas de un solo uso](https://pre.kymos.com/es/news/usp-extraibles-y-lixiviables-en-sistemas-de-un-solo-uso/)
- [미국 특허<665> /<1665> 일회용 시스템의 추출물 및 용출물](https://pre.kymos.com/ko/news/%eb%af%b8%ea%b5%ad-%ed%8a%b9%ed%97%88-%ec%9d%bc%ed%9a%8c%ec%9a%a9-%ec%8b%9c%ec%8a%a4%ed%85%9c%ec%9d%98-%ec%b6%94%ec%b6%9c%eb%ac%bc-%eb%b0%8f-%ec%9a%a9%ec%b6%9c%eb%ac%bc/)
- [USP <665>/<1665>：一次性使用系统中的提取物和浸出物](https://pre.kymos.com/zh-hans/news/usp-%ef%bc%9a%e4%b8%80%e6%ac%a1%e6%80%a7%e4%bd%bf%e7%94%a8%e7%b3%bb%e7%bb%9f%e4%b8%ad%e7%9a%84%e6%8f%90%e5%8f%96%e7%89%a9%e5%92%8c%e6%b5%b8%e5%87%ba%e7%89%a9/)
- [바이오시밀러 개발: 3상부터 분석 비교성 및 PK/PD까지](https://pre.kymos.com/ko/news/%eb%b0%94%ec%9d%b4%ec%98%a4%ec%8b%9c%eb%b0%80%eb%9f%ac-%ea%b0%9c%eb%b0%9c-3%ec%83%81%eb%b6%80%ed%84%b0-%eb%b6%84%ec%84%9d-%eb%b9%84%ea%b5%90%ec%84%b1-%eb%b0%8f-pk-pd%ea%b9%8c%ec%a7%80/)
- [生物类似药开发：从 III 期临床到分析可比性及 PK/PD](https://pre.kymos.com/zh-hans/news/%e7%94%9f%e7%89%a9%e7%b1%bb%e4%bc%bc%e8%8d%af%e5%bc%80%e5%8f%91%ef%bc%9a%e4%bb%8e-iii-%e6%9c%9f%e4%b8%b4%e5%ba%8a%e5%88%b0%e5%88%86%e6%9e%90%e5%8f%af%e6%af%94%e6%80%a7%e5%8f%8a-pk-pd/)
- [Biosimilar Development: From Phase III to Analytical Comparability and PK/PD](https://pre.kymos.com/news/biosimilar-development-change/)
- [Sviluppo di farmaci biosimilari: dalla fase III alla comparabilità analitica e alla farmacocinetica/farmacodinamica](https://pre.kymos.com/it/news/sviluppo-di-farmaci-biosimilari-dalla-fase-iii-alla-comparabilita-analitica-e-alla-farmacocinetica-farmacodinamica/)
- [Desenvolupament de biosimilars: de la fase III a la comparabilitat analítica i la farmacocinètica/farmacèutica](https://pre.kymos.com/ca/news/biosimilar-development-change/)
- [Biosimilar-Entwicklung: Von Phase III zur analytischen Vergleichbarkeit und PK/PD](https://pre.kymos.com/de/news/biosimilar-entwicklung-von-phase-iii-zur-analytischen-vergleichbarkeit-und-pk-pd/)
- [Desarrollo de biosimilares: de la fase III a la comparabilidad analítica y farmacocinética/farmacodinámica.](https://pre.kymos.com/es/news/biosimilar-development-change/)
- [Développement des biosimilaires : de la phase III à la comparabilité analytique et à la pharmacocinétique/pharmacodynamique](https://pre.kymos.com/fr/news/developpement-des-biosimilaires-de-la-phase-iii-a-la-comparabilite-analytique-et-a-la-pharmacocinetique-pharmacodynamique/)
- [OligoXplorer: Our CMC Platform for Oligonucleotide Therapeutics](https://pre.kymos.com/news/oligoxplorer/)
- [OligoXplorer: La nostra plataforma CMC per a oligonucleòtids terapèutics](https://pre.kymos.com/ca/news/oligoxplorer/)
- [OligoXplorer: Nuestra plataforma CMC para oligonucleótidos terapéuticos](https://pre.kymos.com/es/news/oligoxplorer/)
- [OligoXplorer: 올리고뉴클레오티드 치료제를 위한 CMC 플랫폼](https://pre.kymos.com/ko/news/oligoxplorer-%ec%98%ac%eb%a6%ac%ea%b3%a0%eb%89%b4%ed%81%b4%eb%a0%88%ec%98%a4%ed%8b%b0%eb%93%9c-%ec%b9%98%eb%a3%8c%ec%a0%9c%eb%a5%bc-%ec%9c%84%ed%95%9c-cmc-%ed%94%8c%eb%9e%ab%ed%8f%bc/)
- [OligoXplorer: la nostra piattaforma CMC per la terapia oligonucleotidica](https://pre.kymos.com/it/news/oligoxplorer-la-nostra-piattaforma-cmc-per-la-terapia-oligonucleotidica/)
- [OligoXplorer: Unsere CMC-Plattform für Oligonukleotid-Therapeutika](https://pre.kymos.com/de/news/oligoxplorer-unsere-cmc-plattform-fuer-oligonukleotid-therapeutika/)
- [OligoXplorer : Notre plateforme CMC pour les thérapies oligonucléotidiques](https://pre.kymos.com/fr/news/oligoxplorer-notre-plateforme-cmc-pour-les-therapies-oligonucleotidiques/)
- [OligoXplorer：我们的寡核苷酸疗法 CMC 平台](https://pre.kymos.com/zh-hans/news/oligoxplorer%ef%bc%9a%e6%88%91%e4%bb%ac%e7%9a%84%e5%af%a1%e6%a0%b8%e8%8b%b7%e9%85%b8%e7%96%97%e6%b3%95-cmc-%e5%b9%b3%e5%8f%b0/)
- [중화 항체: 생물학 제제에 대한 테스트, 지침 및 영향](https://pre.kymos.com/ko/news/%ec%a4%91%ed%99%94-%ed%95%ad%ec%b2%b4-%ec%83%9d%eb%ac%bc%ed%95%99-%ec%a0%9c%ec%a0%9c%ec%97%90-%eb%8c%80%ed%95%9c-%ed%85%8c%ec%8a%a4%ed%8a%b8-%ec%a7%80%ec%b9%a8-%eb%b0%8f-%ec%98%81%ed%96%a5/)
- [Anticorpi neutralizzanti: test, linee guida e impatto sui farmaci biologici](https://pre.kymos.com/it/news/anticorpi-neutralizzanti-test-linee-guida-e-impatto-sui-farmaci-biologici/)
- [Neutralisierende Antikörper: Testverfahren, Richtlinien und Auswirkungen auf Biologika](https://pre.kymos.com/de/news/neutralisierende-antikoerper-testverfahren-richtlinien-und-auswirkungen-auf-biologika/)
- [Anticorps neutralisants : tests, lignes directrices et impact sur les produits biologiques](https://pre.kymos.com/fr/news/anticorps-neutralisants-tests-lignes-directrices-et-impact-sur-les-produits-biologiques/)
- [中和抗体：生物制品的检测、指南及影响](https://pre.kymos.com/zh-hans/news/%e4%b8%ad%e5%92%8c%e6%8a%97%e4%bd%93%ef%bc%9a%e7%94%9f%e7%89%a9%e5%88%b6%e5%93%81%e7%9a%84%e6%a3%80%e6%b5%8b%e3%80%81%e6%8c%87%e5%8d%97%e5%8f%8a%e5%bd%b1%e5%93%8d/)
- [Neutralizing Antibodies: Testing, Guidelines and Impact for Biologics](https://pre.kymos.com/news/neutralizing-antibodies-testing/)
- [Anticossos neutralitzants: anàlisi, directrius i impacte per als productes biològics](https://pre.kymos.com/ca/news/analisi-anticossos-neutralitzants/)
- [Anticuerpos neutralizantes: análisis, directrices e impacto en los productos biológicos](https://pre.kymos.com/es/news/analisis-anticuerpos-neutralizantes/)
- [Dissolution Testing: What it is, How we do it, and Why it matters](https://pre.kymos.com/news/what-is-dissolution-testing/)
- [용해 테스트: 용해 테스트란 무엇이고, 어떻게 진행하며, 왜 중요한가](https://pre.kymos.com/ko/news/%ec%9a%a9%ed%95%b4-%ed%85%8c%ec%8a%a4%ed%8a%b8-%ec%9a%a9%ed%95%b4-%ed%85%8c%ec%8a%a4%ed%8a%b8%eb%9e%80-%eb%ac%b4%ec%97%87%ec%9d%b4%ea%b3%a0-%ec%96%b4%eb%96%bb%ea%b2%8c-%ec%a7%84%ed%96%89%ed%95%98/)
- [Test di dissoluzione: cos'è, come lo eseguiamo e perché è importante](https://pre.kymos.com/it/news/test-di-dissoluzione-cose-come-lo-eseguiamo-e-perche-e-importante/)
- [Auflösungsprüfung: Was sie ist, wie wir sie durchführen und warum sie wichtig ist](https://pre.kymos.com/de/news/aufloesungspruefung-was-sie-ist-wie-wir-sie-durchfuehren-und-warum-sie-wichtig-ist/)
- [Tests de dissolution : définition, méthode et importance](https://pre.kymos.com/fr/news/tests-de-dissolution-definition-methode-et-importance/)